SCRI Development Innovations   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Nashville TN United States (1993)

Organization Overview

First Clinical Trial
1998
NCT00193531
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sara Cannon Research Institute | Sarah Cannon | Sarah Cannon Cancer Center | Sarah Cannon Development Innovations | Sarah Cannon Research Insititute | Sarah Cannon Research Instititue (SCRI) | Sarah Cannon Research Institute-Denver | Sarah Cannon Research Institute; Denver, Colorado 80218 USA | Sarah Cannon Research Institute HealthOne, Denver, CO | Sarah Cannon Research Institute, Nashville, Tennessee | Sarah Cannon Research Institute; Nashville, Tennessee 37203, USA | Sarah Cannon Research Institute (SCRI) | Sarah Cannon Research Institute, UK | Sarah Cannon Research Institute United Kingdom | Sarah Cannon Research Institute, United Kingdom | Sarch Cannon Research Institute | SCRI | SCRI Development Innovations, LLC | SCRI Innovations | SCRI-Tennessee Oncology | Tennessee Oncology / Sarah Cannon | The Sarah Cannon Research Institute